Recently, Professor Liu Kangdong and Professor Dong Zigang of Zhengzhou University published their research Erianin Suppresses Constitutive Activation of MAPK Signaling Pathway by Inhibition of CRAF and MEK1 / 2 in the international journal Signal Transduction and Targeted Therapy. Dr. Wang Penglei, Dr. Jia Xuechao and Dr. Lu Bingbing are co-first authors of the article, and Professor Dong Zigang and Liu Kangdong are co-corresponding authors of the article. The research was supported by the National Natural Science Foundation of China.